![]() BAYN 1 month ago | Other | €0.1 Per Share |
![]() BAYN 29 Apr 2024 | Other | €0.1 Per Share |
![]() BAYN 2 May 2023 | Other | €2.08 Per Share |
![]() BAYN 2 May 2022 | Other | €1.73 Per Share |
![]() BAYN 28 Apr 2021 | Other | €1.73 Per Share |
6 Aug 2025 (49 Days) Date | | - Cons. EPS | - EPS |
13 May 2025 Date | | - Cons. EPS | - EPS |
5 Mar 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
6 Aug 2024 Date | | 0.88 Cons. EPS | 0.94 EPS |
![]() BAYN 1 month ago | Other | €0.1 Per Share |
![]() BAYN 29 Apr 2024 | Other | €0.1 Per Share |
![]() BAYN 2 May 2023 | Other | €2.08 Per Share |
![]() BAYN 2 May 2022 | Other | €1.73 Per Share |
![]() BAYN 28 Apr 2021 | Other | €1.73 Per Share |
6 Aug 2025 (49 Days) Date | | - Cons. EPS | - EPS |
13 May 2025 Date | | - Cons. EPS | - EPS |
5 Mar 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
6 Aug 2024 Date | | 0.88 Cons. EPS | 0.94 EPS |
Drug Manufacturers - General Industry | Healthcare Sector | Mr. William N. Anderson CEO | XMUN Exchange | - ISIN |
Germany Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Bayer Aktiengesellschaft is a global life science company with a diversified portfolio that spans across Pharmaceuticals, Consumer Health, and Crop Science segments. Having been founded in 1863, Bayer has solidified its presence worldwide, engaging in activities that range from the development of prescription medicines and consumer health products to innovations in agriculture. The company is committed to leveraging scientific advancements to address some of the most pressing challenges in healthcare and agriculture. Bayer’s collaborations with institutions such as Acuitas Therapeutics, Inc., Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc., underscore its dedication to pushing the boundaries of what is possible in science. With a strong distribution network that includes wholesalers, pharmacies, supermarkets, online retailers, and hospitals, as well as direct connections to farmers, Bayer ensures its products and solutions are accessible globally. The company’s headquarters are located in Leverkusen, Germany, reflecting its roots and long-standing history.
This segment focuses on prescription products in cardiology, women's health care, specialty therapeutics in oncology, hematology, and ophthalmology. Bayer also provides diagnostic imaging equipment and digital solutions, contrast agents, as well as pioneering in cell and gene therapy. Through collaboration with entities like Acuitas Therapeutics, Inc. and Peking University, Bayer advances in gene editing and pharmaceutical research.
Under the Consumer Health segment, Bayer markets a wide range of nonprescription over-the-counter medicines targeting self-medication and self-care needs. These include nutritional supplements, allergy relief, cough and cold solutions, dermatology products, pain and cardiovascular risk prevention medications, and digestive health products. Bayer’s approach to consumer health emphasizes safety and efficacy, providing reliable options for daily health and wellness.
The Crop Science segment contributes to agriculture through seeds, plant traits enhancements, chemical and biological crop protection products, digital agriculture solutions, and extensive customer service. Bayer focuses on increased agricultural productivity and sustainability, offering solutions like seed breeding, propagation, and production/processing, including seed dressing. Collaborations with institutions such as the Swiss Tropical and Public Health Institute for the development of emodepside showcase Bayer's commitment to addressing global agricultural challenges.
Bayer places a strong emphasis on collaboration, partnering with leading universities, research institutes, and companies to enhance its product pipeline and explore new therapeutic areas. These partnerships, including those with Hologic, Inc. in diagnostic imaging for breast cancer detection, Twist Bioscience Corporation in antibody-based pharmaceuticals research, and others, demonstrate Bayer’s commitment to innovation and advancing health care and agricultural practices.